Filing Details
- Accession Number:
- 0000950170-24-029542
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-11 20:09:29
- Reporting Period:
- 2024-03-08
- Accepted Time:
- 2024-03-11 20:09:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1582313 | Xenon Pharmaceuticals Inc. | XENE | Pharmaceutical Preparations (2834) | 980661854 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1826361 | A. Elizabeth Garofalo | 200 - 3650 Gilmore Way Burnaby A1 V5G 4W8 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2024-03-08 | 3,500 | $18.56 | 3,500 | No | 4 | M | Direct | |
| Common Shares | Disposition | 2024-03-08 | 1,408 | $46.16 | 2,092 | No | 4 | F | Direct | |
| Common Shares | Disposition | 2024-03-08 | 2,092 | $45.69 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Shares | Stock Option (Right to Buy) | Disposition | 2024-03-08 | 3,500 | $0.00 | 20,000 | $18.56 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 16,500 | 2031-06-02 | No | 4 | M | Direct |
Footnotes
- Represents the closing price of the Company's common shares on March 7, 2024 for purposes of net settlement calculations.
- One-third of the total shares subject to the Option vested on the one year anniversary of the grant date, one-third of the total shares subject to the Option vested on the two year anniversary of the grant date, and one-third of the total shares subject to the Option shall vest on the three year anniversary of the grant date.
Billionaire Hedge Funds
